Daniel H. Petroni, MD, PhD
Dr. Petroni holds both a medical degree and PhD in pharmacology from Tulane University School of Medicine. He then completed his internship and residency in Pediatrics at the University of California Davis Medical Center in 2014, followed by an Allergy and Immunology fellowship at the University of Washington in 2016. He has special interest in patients with food & drug allergy, immunodeficiency, and hereditary angioedema.
Dr. Petroni is deeply involved in clinical and basic allergy research and is Executive Director of the Seattle Allergy & Asthma Research Institute (previously ASTHMA Clinical Research Center) and the Northwest Food Allergy Treatment & Research Center (NWFAC). He is the primary investigator on numerous research studies including studies on asthma, urticaria, origins and etiology of food allergy, and new food immunotherapies.
Dr. Petroni sees patients in our Seattle and Renton offices.
- Medical School: Tulane University School of Medicine
- Postgraduate: Tulane University School of Medicine (PhD)
- Residency: University of California Davis Medical Center (2014)
- Fellowship: University of Washington (2016)
Professional Memberships & Affiliations
- American Academy of Allergy, Asthma and Immunology (AAAAI)
- American College of Allergy, Asthma and Immunology (ACAAI)
- Food Allergy and Research Education (FARE)
- Washington State Medical Association (WSMA)
Awards and Recognition
Paracelsus Award of Excellence in the Field of Pharmacology 2011
Tilles SA, Petroni D. FDA-approved peanut allergy treatment: The first wave is about to crest. Ann Allergy Asthma Immunol. 2018 Aug;121(2):145-149. doi: 10.1016/j.anai.2018.06.005. Epub 2018 Jul 6. PMID: 29909055
Sun A, Alshuaibi W, Petroni D, Skoda-Smith S, Goldberg MJ, Hale S. Immune modulation in a patient with Morquio syndrome treated with enzyme replacement therapy. J Allergy Clin Immunol Pract. 2018 Feb 6. pii: S2213-2198(18)30009-6. doi: 10.1016/j.jaip.2017.12.024. PMID: 29426755
Petroni D, Spergel JM. Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy. Ann Allergy Asthma Immunol. 2018 Mar;120(3):237-240.e4. doi: 10.1016/j.anai.2017.11.016. Epub 2018 Feb 1. PMID: 29397272
Ochs HD, Petroni D. From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders. Am J Med Genet A. 2018 Apr;176(4):784-803. doi: 10.1002/ajmg.a.38480. Epub 2017 Sep 21. Review. PMID: 28941161
Petroni DH, Aitken ML, Ham E, Chung S, Menalia L, Altman MC, Ayars AG. Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis. Ann Allergy Asthma Immunol. 2016 Oct;117(4):378-381. doi: 10.1016/j.anai.2016.07.039. Epub 2016 Aug 31.PMID: 27590641
What Patients Say
“Dr. Petroni is amazing. He explained everything clearly and answer my many questions. He and all the staff were very kind. I felt very well taken care of.”
~Lori P. Seattle